Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen and nitrogen species (RONS) and redox systems comprise a broad array of reactive molecules and the integrated enzymatic networks that maintain cellular redox homeostasis [Sies et al., 2017, Nature Reviews Molecular Cell Biology]. RONS, including superoxide, hydrogen peroxide, and nitric oxide, are generated through metabolic processes or by specific enzymes like NADPH oxidases (NOX) and nitric oxide synthases (NOS) [Holmström & Finkel, 2014, Nature Reviews Molecular Cell Biology]. These species function as vital secondary messengers in physiological signaling pathways, regulating cell growth, differentiation, and immune responses [Di Meo et al., 2016, International Journal of Molecular Sciences]. However, an imbalance known as oxidative or nitrosative stress occurs when RONS production exceeds the capacity of antioxidant defenses, leading to damage of DNA, proteins, and lipids [Forman & Zhang, 2021, Nature Reviews Drug Discovery]. This imbalance is a key driver in the progression of various diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions like Alzheimer's disease [Murphy et al., 2022, Nature Reviews Drug Discovery]. Pharmacological strategies targeting these systems involve direct scavenging of radicals, inhibition of RONS-producing enzymes, or the activation of endogenous antioxidant pathways, such as the Nrf2/ARE system [Kansanen et al., 2013, Redox Biology]. Despite their therapeutic potential, the clinical application of redox-modulating drugs is complicated by the need for precise targeting to avoid disrupting essential physiological redox signaling [Murphy et al., 2022, Nature Reviews Drug Discovery].
Free radical scavenging, inhibition of ROS-generating enzymes (e.g., NOX, xanthine oxidase), and activation of antioxidant transcription factors (e.g., Nrf2).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen and nitrogen species and redox systems (RONS/Redox).